Indeed, mutations in other RAS pathway genes, such as the upstream regulators SOS1, SOS2, GRB2 and PTPN11 (also known as SHP2) and in genes encoding downstream effectors MEK1/2 and ERK1/2, can be detected in ≤5% of cutaneous melanomas. Here, PTPN11 is linked to cutaneous melanoma.